A new strategy to combat the multidrug resistant/metastatic triple negative breast cancers via therapeutically targeting by autoimmune medication: Atacicept

First Author / 第一作者

Hui-Yu Lin

Institution / 單位

天主教耕莘醫院新店總院; 輔仁大學醫學院醫學系 -Department of Breast Surgery and General Surgery, Division of Surgery, Cardinal Tien Hospital, Xindian, New Taipei, Taiwan -School of Medicine, College of Medicine, Fu Jen Catholic University, Taipei, Taiwan

Audio / 音訊檔

Author Group / 作者群

Mary Ann Lou, MD.Ph.,1,2 Tzu-Hung Chen, MD .,1 Yi-Husan Hu, MD.,1 Chia-Hui Li, M.S.1 Hsiang-Chun Jan, MD.,1 Chi-Long Chen, MD.Ph.D.,4,5 Yuan-Feng Lin, PhD.5

Author Group Institution/ 作者群單位

1.Department of Breast Surgery and General Surgery, Division of Surgery, Cardinal Tien Hospital, Xindian, New Taipei, Taiwan 2.School of Medicine, College of Medicine, Fu Jen Catholic University, Taipei, Taiwan 4.Department of Pathology, College of Medicine, Taipei Medical University, Taipei, Taiwan 5.Department of Pathology, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan

Category / 主題分類

Basic Research

Keyword / 關鍵字

Triple negative breast cancers, Atacicept, autoimmune

Back to list